In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on HCA Healthcare Inc (NYSE: HCA). The company’s shares closed yesterday at $129.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 15.1% and a 70.1% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.
HCA Healthcare Inc has an analyst consensus of Strong Buy, with a price target consensus of $148.73, implying a 15.3% upside from current levels. In a report released today, Cantor Fitzgerald also maintained a Buy rating on the stock with a $135 price target.
.
See today’s analyst top recommended stocks >>
HCA Healthcare Inc’s market cap is currently $44.73B and has a P/E ratio of 16.25. The company has a Price to Book ratio of -7.47.
Based on the recent corporate insider activity of 125 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. The company was founded on November 22, 2010 and is headquartered in Nashville, TN.
